MYCN and neuroblastoma: Among these morphologic indicators, there is a reproducible relationship between MYCN amplification and increased MKI classes [14, 15]: Our recent study confirmed that 68% of High-MKI, 15% of Intermediate-MKI, and only 3% of Low-MKI neuroblastomas had MYCN oncogene amplification [16].